MEDYSSEY Co.,Ltd (XKON:200580)

bluebird bio Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2014	FY 2013
Period Ending	Dec 31, 2014	Dec 31, 2013
Cash & Equivalents	1,814	487.99
Short-Term Investments	2,392	320.5
Cash & Short-Term Investments	4,206	808.49
Cash Growth	420.20%	-
Accounts Receivable	3,884	2,899
Other Receivables	69.77	158.28
Receivables	4,142	3,218
Inventory	4,755	4,122
Prepaid Expenses	11.51	13.54
Other Current Assets	115.2	151.47
Total Current Assets	13,230	8,314
Property, Plant & Equipment	3,638	2,936
Long-Term Investments	272.8	272.8
Other Intangible Assets	29.44	42.85
Other Long-Term Assets	415.46	358.19
Total Assets	17,586	11,924
Accounts Payable	194.13	207.66
Accrued Expenses	11.9	8.15
Short-Term Debt	2,016	2,818
Other Current Liabilities	1,368	1,393
Total Current Liabilities	3,590	4,427
Long-Term Debt	1,000	-
Other Long-Term Liabilities	45	45
Total Liabilities	4,635	4,472
Common Stock	804.55	705
Additional Paid-In Capital	3,359	-
Retained Earnings	8,726	6,747
Total Common Equity	12,889	7,452
Shareholders' Equity	12,951	7,452
Total Liabilities & Equity	17,586	11,924
Total Debt	3,016	2,818
Net Cash (Debt)	1,190	-2,009
Net Cash Per Share	739.40	-1425.84
Filing Date Shares Outstanding	1.61	1.41
Total Common Shares Outstanding	1.61	1.41
Working Capital	9,641	3,887
Book Value Per Share	8007.45	5288.95
Tangible Book Value	12,860	7,409
Tangible Book Value Per Share	7989.16	5258.54
Land	396.01	396.01
Buildings	1,029	1,029
Machinery	3,760	3,466
Construction In Progress	940.39	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.